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There has been a surge of availability and use for research of routinely collected 
 electronic health data, such as electronic health records, health administrative data, 
and disease registries. Symptomatic of this surge, in 2012, Pharmacoepidemiology 
and Drug Safety (PDS) published a supplemental issue containing several reviews 
of validated methods for identifying health outcomes using routine health data,1 
focusing on databases feeding the US Mini-Sentinel Program.2 In one of the review 
papers of the PDS Supplement, Carnahan3 acknowledged that while ample validated 
algorithms exist for major health events, for example, cardiovascular events, vali-
dated methods of identifying many health outcomes are lacking. Furthermore, the 
referenced studies focused on algorithms based on coding sets used in the United 
States (eg, ICD-9) to identify events from US databases, set within the US health 
care system. This leaves out an entire segment of routine databases, most notably, 
Nordic national registries or other European databases such as Clinical Practice 
Research Datalink (CPRD), The Heatlh Improvement Network (THIN) Hospital 
Episode Statistics (HES), or PHARMO, all of which are set in health care systems 
that are differently run and financed than those in the United States. Since other 
systems function differently, and the databases contain different variables, valida-
tion of health status in US data may not always be generalizable.5–9 Many validation 
studies have been done among these various resources,10–12 but the work is far from 
complete, as shown in a systematic review of validation studies of the UK-based 
Clinical Practice Research Datalink, published in 2010.13 Some algorithms may 
become outdated because of changes in coding or medical practices; new diseases, 
without clear representation in classification systems, may emerge. Furthermore, 
in October 2015, the United States adopted ICD-10,14 while ICD-11 is looming 
on the horizon.15
Clinical Epidemiology has published and continues to publish studies that describe 
the validity of algorithms in routinely recorded health data, such as validation of 
medication use in hospitals,16,17 cancer characteristics and complications,18–20 or 
events related to reproductive and fetal medicine,21,22 to name just a few examples. 
An “algorithm” in the present context refers to a combination of values of routinely 
collected variables that allow identification of cases of a given disease or other health 
event without having to contact or examine the patient. For example, an algorithm 
based on a combination of diagnostic ICD-10 codes E10-E11 and medication ATC 
Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
50
Ehrenstein et al
codes A10 may identify patients with diabetes. The com-
monly evaluated aspects of an algorithm’s validity are 
positive predictive value (proportion of algorithm-positive 
patients who truly have the disease of interest) and sensitiv-
ity (proportion of patients with the disease of interest who 
are algorithm-positive), and their counterparts negative 
predictive value (proportion of algorithm-negative persons 
without the disease of interest) and specificity (proportion 
of persons without the disease who are algorithm-negative). 
Validity of entire data sources is commonly measured by 
their completeness (proportion of true cases of a disease 
captured by a data source). A comprehensive review of 
methods for validating algorithms to identify disease cohorts 
from health administrative data, with accompanying report-
ing guidelines for such work, was published by the Journal 
of Clinical Epidemiology in 2011.23
Clinical Epidemiology is hereby issuing a targeted call 
for papers that report on results of validation studies. We are 
interested in publishing both original validation studies and 
systematic reviews, using various types of reference (“gold”) 
standards, such as review of medical charts or comparison 
with other data sources. Several resources are available to 
guide reporting, including the 2011 guidelines mentioned 
above,23 as well as the STARD Checklist,24 and the RECORD 
Checklist.25,26 Please take advantage of these resources in 
preparing your high-quality submissions.
Some may think of validation work as mundane, a mere 
poor relative of the “real” original research. We subscribe 
to a different viewpoint. First, misclassification of study 
variables threatens the validity of research findings.27 Since 
epidemiologic research is “an exercise in measurement”,28 
high-quality original research is unthinkable without accu-
rate or accurately calibrated instruments. In our editorial 
experience, evidence of data validity is routinely requested 
by article referees. Second, following from above, results of 
validation studies allow epidemiologists to assess the extent 
of misclassification and estimate its impact on the study 
results. Third, shining the spotlight on validation studies 
may activate a feedback loop: physicians may become even 
more motivated to use systematic coding schemes keeping in 
mind that the data they feed into the routine databases will be 
used for research that will ultimately benefit their patients. 
Last, but not least, validation studies are frequently cited. 
For example, systematic reviews by Khan et al29 and Herrett 
et al,13 published in 2010, have already received more than 
240 and 350 citations, respectively. We hope you find our 
arguments compelling and look forward to receiving your 
validation study submissions.
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